Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. | Chief Medical Officer | Common Stock | 91K | $1.02M | $11.26 | Mar 2, 2022 | Direct |
Aurinia Pharmaceuticals Inc. | Chief Medical Officer | Stock Option (right to buy) | 125K | Mar 2, 2022 | Direct | ||
Aurinia Pharmaceuticals Inc. | Chief Medical Officer | Restricted Stock Unit | 72.9K | Mar 2, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2022 | 4 | -$58.2K | 4 | Mar 4, 2022 | Chief Medical Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Nov 9, 2021 | 10 | -$6.4M | 4 | Nov 12, 2021 | Chief Medical Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Nov 1, 2021 | 3 | -$1.19M | 4 | Nov 3, 2021 | Chief Medical Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Sep 10, 2021 | 3 | -$2.5M | 4 | Sep 14, 2021 | Chief Medical Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Aug 25, 2021 | 1 | -$79.3K | 4 | Aug 26, 2021 | Chief Medical Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Aug 9, 2021 | 1 | -$721K | 4 | Aug 10, 2021 | Chief Medical Officer |